Heartsciences announces canada patent grant covering myovista® wavelet technology

Southlake, tx, march 06, 2024 (globe newswire) -- heart test laboratories, inc. d/b/a heartsciences (nasdaq: hscs; hscsw) (“heartsciences” or the “company”), an artificial intelligence (ai)-powered medical technology company focused on transforming ecgs/ekgs to save lives through earlier detection of heart disease, today announced that the canadian intellectual property office application no. 3,000,369 has been granted by the canadian intellectual property office.
HSCS Ratings Summary
HSCS Quant Ranking